Studies of the pathophysiological role of NF-κB in the liver have found that NF-κB is a central link between liver inflammation, fibrosis and hepatocellular carcinoma, suggesting that the NF-κB signaling pathway is a potential aim for preventing or even delay the advance of liver fibrosis (60). Here, NFKB1 is linked to hepatocellular carcinoma.